The multidisciplinary management of gastro-oesophageal junction tumours
- 30 August 2016
- journal article
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 48 (11), 1283-1289
- https://doi.org/10.1016/j.dld.2016.08.112
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in IsraelOncology Letters, 2012
- T raditional i nvasive vs. m inimally invasive e sophagectomy: a multi-center, randomized trial (TIME-trial)BMC Surgery, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- What reasons lie behind long-term survival differences for gastric cancer within Europe?European Journal of Cancer, 2010
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische OnkologieJournal of Clinical Oncology, 2008
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerThe New England Journal of Medicine, 2008
- Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal EsophagusAnnals of Surgery, 2007
- Referral Patterns, Treatment Choices, and Outcomes in Locoregional Esophageal Cancer: A Population-Based Analysis of Elderly PatientsJournal of Clinical Oncology, 2007
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006
- Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumabAnnals of Oncology, 2005